66 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
investigation or administrative proceeding which could result in Executive being) (i) debarred or (ii) excluded from participation in any federally … of the Company’s investigation thereof, which relate to the business of the Company or any of its affiliates or subsidiaries (the “Business”) at any time during
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
in this Agreement limits your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
opinion, TD Cowen, at the direction of the Adaptimmune Board, assumed and relied, without independent investigation, upon the accuracy and completeness … necessary or appropriate in connection with its investigation of the other party with respect to the transactions contemplated by the merger
S-4/A
wf3f 90i9d7f2ow
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
4uscxaa
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
oyp7avi ga
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.01
83c7nh9pufb
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
smm6t
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
9bhgahnfuz6yi5mc
28 Aug 20
Regulation FD Disclosure
10:44am
S-3ASR
EX-1.2
d4s3ibdx9dlxbdfvbw
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-1.1
udnq n14ckwayr
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm